15 news items
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
IDYA
31 May 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today
IDEAYA Biosciences to Participate in Upcoming June 2024 Investor Relations Events
IDYA
29 May 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted
IDEAYA Biosciences Appoints Daniel A. Simon as Chief Business Officer to Lead Corporate Strategy and Business Development
IDYA
28 May 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, today announced
IDEAYA Biosciences Announces Abstract Summary Results of ASCO 2024 Oral Presentation for Phase 2 Investigator Sponsored Study of Darovasertib in Neoadjuvant Uveal Melanoma
IDYA
23 May 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development
Unveiling 5 Analyst Insights On IDEAYA Biosciences
IDYA
8 May 24
Biosciences
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted
4e9gmcc46ggij9e4mv1q88
IDYA
7 May 24
company committed to the discovery and development of targeted therapeutics, provided a business update, and announced financial results for the first
5zfrg5w8l533jykevrq4c7m5228ow rcp7er3z4j9noa0fe29n4lx
IDYA
1 May 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics
5zv22cz7r fyfw02g1dpqi4r
IDYA
26 Apr 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted
ayh4a04c73f59j96kyhg67sg2ziq42n5h
IDYA
24 Apr 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery
g6c6 6et15w0hssrdykyina
IDYA
22 Apr 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery
60dze6qota4pifzx9jh7n72kc7myas2vodv5ggjhppknrw
IDYA
5 Apr 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted
3fc 65orcbgjc932ngjh7ayjv9k
IDYA
1 Apr 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted
l8ozih57530 bhtwczgvl8z8gu7ofvjayg2gwewptzz3awd8
IDYA
12 Mar 24
oncology company committed to the discovery and development of targeted therapeutics, today announced that it has entered into a clinical trial
xv1mb64a x6fjg6v5b3km23j9mmmjz81dm
IDYA
8 Mar 24
Biosciences's Background
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted
h4esj
IDYA
4 Mar 24
. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced
- Prev
- 1
- Next